Dr. Rouse is a native of England where he completed his education through a the BVSc honors degree. Graduate education in Canada with MSc in Virology and PhD in immunology Postdoctoral fellowship at Walter and Eliza Hall of Medical Research in Melbourne Australia in Cellular Immunology 1970-72.Established research Program at University of Saskatchewan on Viral immunology supported by Medical Research Council of Canada.Moved to College of Veterinary Medicine University of Tennessee in 1977 where he remains as the Lindsay Young Distinguished Professor Took several mainly sabbaticals, including one with Peter Doherty (another veterinarian) in Canberra and Hermann Wagner for one year in Mainz, Germany Worked on the immunology of herpesvirus infections supported continuously by multiple NIH grants until the lad was closed in Dec 2022.Published >470 research articles and reviews with and h index 91 and won several Research Achievement awards. Trained 80 PhD and postdoctoral fellows most of whom he stays in contact and occasionally writes reviews on topics in Viral Immunology.
Dr. De-chu Chris Tang is the Founder CEO of VaxDome Inc. He and his associates were the first to have developed DNA vaccines, skin-patch vaccines, antiviral/vaccine hybrids and in vivo cytotoxicity assay, etc. Dr. Tang obtained his PhD degree from Indiana University. He founded Vaxin Inc. when he was an assistant professor at University of Alabama at Birmingham. VaxDome Inc. is located on University of North Texas Health Science Center campus, with a focus on the development of an antiviral/vaccine/vaccine potentiator package without constraints imposed by viral mutations; as well as a tissueresident cellular immunity assay with missing-in-action T cells excluded.
Nagy is a founder and was the Head of R&D of Mina therapeutics whilst at Mina he was driving the development of saRNA drug (a new class of medicines) which is currently being trialled in patients with liver cancer in eight UK centres, and sites in Singapore and Taiwan.second trial in patients with solid tumours in the UK, USA, Europe, Singapore and Taiwan.He has published widely in gene therapy, stem cell therapy, oligonucleotides, endoscopy and surgery. Currently he is the CEO of Apterna Limited, a company focussed on novel oligonucleotide delivery and Dawn Therapeutics specialising in gene therapy. Previously Nagy was founder and Chairman of EMcision Limited (acquired by Boston Scientific Inc in 2018).Nagy is Lead Clinician and Head of the Department of HPB Surgery at Imperial College London.
Daniel Salmon, PhD ’03, MPH, is a vaccinologist who conducts epidemiological and behavioral studies to assess the safety of vaccines and improve vaccine decision-making. Research Interests International Health, vaccine; immunization; vaccine safety; mandatory immunization.Dr. Salmon’s primary research and practice interest is optimizing the prevention of childhood infectious diseases through the use of vaccines. He is broadly trained in vaccinology, with an emphasis in epidemiology, behavioral epidemiology, and health policy. Dr. Salmon’s focus has been on post-licensure vaccine safety, determining the individual and community risks of vaccine refusal, understanding factors that impact vaccine acceptance, evaluating and improving state laws providing exemptions to school immunization requirements, developing systems and science in vaccine safety, and effective vaccine risk communication. Dr. Salmon has considerable experience developing surveillance systems, using surveillance data for epidemiological studies, and measuring immunization coverage through a variety of approaches. Dr. Salmon has worked with state and federal and global public health authorities to strengthen immunization programs and pandemic planning. Honors & Awards Haddon Fellow, Johns Hopkins University Bloomberg School of Public Health (1999-2001) Achievement Award – Dedication to Students, Johns Hopkins Bloomberg School of Public Health (2005) Development of the Federal Immunization Safety Task Force, Assistant Secretary for Health (2008) Federal Monitoring of H1N1 Vaccine Safety, Assistant Secretary for Health (2010) Patient Education Working Group Co-Chair, Assistant Secretary for Health (2012)
Prof. Dr. Seyed Saeid, Zamanieh Shahri, is faculty member in California Northstate University, CNSU as well as university Professor in Losrios Community College District, in USA. He is editorial board member in International Medical Journals in United States of America such as Journal of Gynecology and Women’s Health Research in Sciforschen journals in California, International Journal of Computational and Neural Engineering, IJCNE in Delaware , International Journal of Cancer Studies and Research in Delaware, International Journal of Clinical Surgery and Research in Delaware, International Journal of Psychiatry, International Auctores Journal of Clinical Case Reports and Reviews, International Journal of Diabetes and Metabolic Disorders, IJDMD in Kansas, International Journal of Biomedical Research and Practice in Delaware, American Medical Journal of Neurology Research in New Jersey.
Dr. Khoury is a pulmonary and internal medicine consultant at the Technion School of Medicine, Israel, Dr. Khoury earned his M.D. He completed his internship and residency at Rambam Health Care Campus, Haifa, Israel. He then completed a clinical fellowship in pulmonary diseases at Carmel Medical Center. Since then, Dr. Khoury serves as a senior physician at Carmel Medical Center, where he established the first post COVID clinic in north Israel, and at EMMS Nazareth hospital, where he established the pulmonary care unit. Dr. Khoury started his post doctoral fellowship at Yale School of Medicine on 5/2021, where he studies novel pathways for idiopathic pulmonary fibrosis development, at Dr. Kaminski's lab.
Professor Petro Terblanche has a successful track record in the strategic and operational management of technology intensive organizations. She has played a key part in the design and implementation of South Africa’s biotechnology strategy. She holds the position of Chief Executive Officer of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa. Afrigen hosts the WHO Global mRNA technology development and transfer Hub and has a mRNA Covid 19 vaccine candidate in development as part of a global program to build capacity and capabilities in LMICsto design, develop and produce mRNA vaccines.Prof Terblanche is the author of more than 200 scientific publications and conference papers in public health. Petro holds several Board positions and serves on a number of scientific advisory boards in the public health sector. She was recently acknowledged as one of the legends of science by the Academy of Sciences South Africa.
Professor Dr. Luisa Maria Arvide Cambra, Spanish is now Professor with Chair at the University of AlmerÃa (Spain) and she was Assistant Professor and Associate Professor at the University of Granada from 1979 on. Forty nine years of the teaching and researching experience. She is the Director of Research Group HUM113-Estudios Filológicos from Program of Research of Andalusian Government, where she has managed and directed several academic and scientific contracts and research projects, as well as a Member of European Scientific Institute (ESI) Team, Athens Institute for Education & Research (ATINER) in Greece, The Academic Genesis Platform (UAGP) in UK&Turkey and Experts of Academic Excellence Research Centre (EAERC) in Jordan; GI Social Sciences Forum (GISSF), in Malaysia; Akademica Nusa International Association of Social Sciences and Humanities, in UAE; Science Research Association (SCIREA); Academic Fora; Foundation for Social Sciences and Education Research (FSSER); etc. She is reviewer and member of the editorial board in several renowned scientific journals as well as member of the organizing, scientific & academic committees at prestigious international conferences. She is author of a many works on several aspects of the Arabic science and literature in the Middle Ages, as well as Arabic language and linguistics. She has also participated in different prestigious international scientific Conferences. She has visited a many universities and academic institutions of Europe, United States and Arab countries in order to teach and research. Among her works, we have the study and the translation to Spanish of some treatises of Kitab al-tasrif´s Al-Zahrawi, Ibn Qutayba´s texts, Maqamas of Al-Hariri, The Sicilian Questions of Ibn Sab´in, and the book on the plague by Ibn Khatima. Honors and awards -Included and enlisted in Marquis Who´s Who in the World, USA. -Included and enlisted in 2000 Outstanding Intellectuals of the 21st Century 2011. International Biographical Centre. Cambridge, UK. -Included and enlisted in Great Minds of 21st Century, American Biographical Institute. Raleigh, North Carolina, USA. -Top 100 Professionals 2011. International Biographical Centre. Cambridge, UK -Woman of the Year 2011 by the American Biographical Institute. Raleigh, North Carolina, USA. -Deputy Director General for Europe of International Biographical Centre. Cambridge, UK. -Collaborator in QS World Intelligence Unit. London, UK. -International Jury Member of Ana MarÃa Agüero Melnyczuk Awards. Buenos Aires, Argentina. June 2013. -Awarded with honoring certificate by Arab Translators Association (ARTA) (Palestine), in 2021; VDGOOD Professional Association (India), in 2020; etc. Publications 15 books and over 100 articles and papers published in prestigious international journals and proceedings.
Professor in general Surgery.Membership in Societies SurgicalInfectious Society of North America (SIS-NA) and Europe (SIS-E).Head of the Department of General and Pediatric Surgery of the Tashkent Medical Academy, head of the Republican clinics of surgical infection and diabetic foot syndrome. Chief specialist in surgical infection in the Republic of Uzbekistan. Chief consultant for general and emergency surgery of the central city clinic of Tashkent.Prepared 11 PhD and 2 DMs on the problems of diagnosis and treatment of surgical Ñomplications of diabetes mellitus, surgical infection, sepsis, bariatric and metabolic surgery
Dr. Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus†in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings.